This indicates that mdx dystrophic muscles present a decreased SC angiogenic capacity, partly through mechanisms involving a decreased Vegf expression [60] and contributing to the regeneration defect in DMD. The gene discussed is VEGFA; the disease is Duchenne muscular dystrophy.